The Ocular Melanoma Foundation (OMF) is the leading resource for eye cancer research funding and patient/caregiver support. OMF has raised over a million dollars in its quest to #SEEACURE for eye cancer and every year hosts the largest gathering of OM patients in the world.


  • OMF announces the recipient of the AACR-Ocular Melanoma Foundation Career Development Award. This $150K, two-year grant has been awarded to Dr. Alison Skalet, MD, PhD of Oregon Health and Science University. Dr. Skalet's research will explore if hybrid circulating cells can predict the risk of metastasis and eliminate the need for an invasive biopsy. If successful, this project will be the first step in creating a minimal-risk, non-invasive, and repeatable "liquid biopsy" for patients with uveal melanoma. 
  • OMF's strategic partner, Aura Biosciences, recently received clearance from the U.S. FDA to conduct a clinical trial using targeted therapy. This study for light-activated AU-011 for the treatment of patients with small-to-medium primary ocular melanoma is now enrolling in five locations across the country. To learn more, visit or contact

Raising Awareness of Eye Health

Strategic Partners